相关实验视频

Updated: Jul 17, 2025

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

在阿尔茨海默氏病中的微质-星细胞通信

Yingying Wu^1,2, Ulrich L M Eisel¹

¹Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences (GELIFES), University of Groningen, Groningen, The Netherlands.

Journal of Alzheimer's disease : JAD

|August 28, 2023

概括

微质细胞和星球细胞是阿尔茨海默病 (AD) 神经炎症的关键参与者. 了解它们的复杂沟通对于开发新的AD治疗方法至关重要.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

微质细胞和星体细胞是中枢神经系统免疫细胞,参与神经病理学.
在阿尔茨海默氏症 (AD) 等疾病中,它们的激活模式在时间和空间上是不同的.
质细胞介导的神经炎症具有双重作用,可能既有害又有益.

研究的目的:

审查和综合当前关于微质-细胞通信的知识.
突出显示微质细胞和星球细胞在阿尔茨海默病发病过程中的多方面的作用.
强调了解质交叉语音对于新治疗策略的重要性.

主要方法:

文献综述和综合现有关于阿尔茨海默氏症质细胞的研究.
分析详细介绍微质细胞和星体细胞的遗传,细胞和分子反应的研究.
检查质激活的时间和空间模式.

主要成果:

微质激活往往先于天体细胞激活,影响随后的天体细胞反应.
反应性星体细胞可以调节相邻的微质激活,创建复杂的反循环.
微质细胞和星球细胞之间的功能障碍免疫交叉是AD的重要因素.

结论:

微质-质细胞的沟通是复杂的,在阿尔茨海默病中起着关键作用.
向细胞介导的神经炎症为AD提供了潜在的治疗途径.
进一步了解这种交叉语音可以加速开发有效的AD治疗方法.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.天体细胞是什么?天体细胞是什么细胞交叉通话细胞交叉通话微质细胞中的微质细胞神经炎症是一种神经炎症.

更多相关视频

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Published on: July 26, 2024

Culturing Microglia from the Neonatal and Adult Central Nervous System

Culturing Microglia from the Neonatal and Adult Central Nervous System

Published on: August 9, 2013

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Glial Cells

Glial Cells

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...